Physician profile
Robert Guanci
NPI 1619329372
$5,742.49
in general payments reported to CMS, 2019-2025
9 companies · $327 in 2025
The $327 reported for 2025 was more than what 85% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2022: $2,643 · 2023: $2,003 · 2024: $566 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,870 · Travel and Lodging: $1,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,870.34 |
| Travel and Lodging | $1,026.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $5,368.19 | 2022-2025 | |
| Dentsply Sirona INC | $75.75 | 2021 | |
| Align Technology, INC. | $64.88 | 2023-2025 | Invisalign, Itero Element 5d Plus |
| Colgate Oral Pharmaceuticals, INC. | $61.18 | 2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $54.63 | 2021-2023 | Arestin, Ossix Plus |
| Zimmer Biomet Holdings, INC. | $39.56 | 2021 | |
| Envista Holdings Corporation | $32.13 | 2024-2025 | Optibond All-In-One, Maxcem Elite |
| Philips North America LLC | $29.12 | 2022-2025 | Cordless Power Flosser Cn L4l |
| Solventum Corporation | $17.05 | 2024 | 3m Filtek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Guanci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.